MedPath

Retrospective observational study of hydrogen gas inhalation on side effect in cancer patients receiving radiatio

Not Applicable
Conditions
Malignant Tumor and Bone Marrow Damage
Registration Number
JPRN-UMIN000035864
Lead Sponsor
Clinic C4, Incorporated Medical Institution Yukokai
Brief Summary

Radiotherapy without hyperbaric hydrogen inhalation significantly reduced white blood cells and platelets, but not red blood cells, hemoglobin and hematocrit. In contrast, radiotherapy with hyperbaric hydrogen gas inhalation significantly attenuated the reducing effects of white blood cells and platelets. The result of this study was reported at 7th Meeting of the Japanese Biomedical Association of Molecular Hydrogen (held on October, 2017).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
23
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bone marrow damage before and after radiotherapy is evaluated by hematological examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath